Dr. Wilson's research interests focus on visceral leishmaniasis, a disease prevalent in many underdeveloped nations. Her studies address several aspects of the pathogenesis of this disease: first, the molecular determinants governing the expression of gp63, a surface protease important for parasite virulence; second, virulence characteristics of Leishmania including their utilization of iron and their resistance to toxic oxidants; third, the cell-mediated immune response to Leishmania and recombinant antigens responsible for eliciting these responses. The latter project is being extended to studies of immunogenetics and immunology in patients with visceral leishmaniasis in a collaborative project with an investigator in Brazil.

• American Association of Immunologists
• Diplomate, American Board of Internal Medicine and Board of Infectious Diseases
• American Society for Microbiology
• American Society of Cell Biology
• American Society for Tropical Medicine and Hygiene
• Infectious Diseases Society of America
• NIH Physician Scientist Award
• NIH FIRST Award
• Phi Beta Kappa

Medical School:
University of Rochester

Residency:
University of Michigan

Fellowship:
University of Virginia